FAILURE MODE EFFECT ANALYSIS TEAM FACILITATOR: A NOVEL ROLE FOR THE ONCOLOGY NURSE TO IMPROVE CHEMOTHERAPY SAFETY

2.50
Hdl Handle:
http://hdl.handle.net/10755/165125
Category:
Abstract
Type:
Presentation
Title:
FAILURE MODE EFFECT ANALYSIS TEAM FACILITATOR: A NOVEL ROLE FOR THE ONCOLOGY NURSE TO IMPROVE CHEMOTHERAPY SAFETY
Author(s):
Sheridan-Leos, Norma; Hartnaft, Steven
Author Details:
Norma Sheridan-Leos, RN MSN AOCN CPHQ, Sr. Clinical Quality Improvement Analyst, M. D. Anderson Cancer Center, Houston, Texas, USA, email: nsherida@mdanderson.org; Steven Hartnaft, MPH, CPHQ, City of Hope, Duarte, California
Abstract:
Chemotherapy is associated with serious and potentially life threatening side effects, and thus has a high risk of causing significant patient harm when errors occur. Throughout the chemotherapy process, from prescribing to patient monitoring, there is a high risk for life threatening errors to occur. The Joint Commission on Accreditation of Healthcare Organizations expects healthcare organizations to conduct an annual proactive risk management activity for high risk processes. Failure Mode Effect Analysis (FMEA) is a proactive risk management assessment that has been successfully used in the non-healthcare industry to prevent errors from occurring. Because oncology nurses have many roles in the chemotherapy process, they are in a unique position to improve this process. The purpose of this project is to describe how an oncology nurse facilitated the FMEA process to proactively improve the safety of the chemotherapy process. The Oncology nurse facilitator used a variation of the FMEA process developed by the manufacturing industry. Using this process, all of the steps involved in chemotherapy were studied, failure modes were identified, risk analysis and prioritization of risk were completed. Then risk reduction techniques were used to proactively improve the chemotherapy process. FMEA is useful in identifying potential errors that oncology nurses and other healthcare team members may not realize exist at the organization. Although conducting a FMEA can not ensure that the chemotherapy process will be ôfail-safe,ö FMEA participants strongly felt that the FMEA process has: 1. Reduced the likelihood of errors occurring, 2. Helped them feel more confident in the chemotherapy process, 3. Improved understanding of the chemotherapy process, 4. Improved the working relationship with other members of the chemotherapy team. Promoting a culture of safety involves shifting from error measurement to a proactive assessment of potential harm. Because of their pivotal role in chemotherapy, oncology nurses are ideally suited to improve chemotherapy safety.
Repository Posting Date:
27-Oct-2011
Date of Publication:
27-Oct-2011
Conference Date:
2007
Conference Name:
32nd Annual Oncology Nursing Society Congress
Conference Host:
Oncology Nursing Society
Conference Location:
Las Vegas, Nevada, USA
Note:
This is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.

Full metadata record

DC FieldValue Language
dc.type.categoryAbstracten_US
dc.typePresentationen_GB
dc.titleFAILURE MODE EFFECT ANALYSIS TEAM FACILITATOR: A NOVEL ROLE FOR THE ONCOLOGY NURSE TO IMPROVE CHEMOTHERAPY SAFETYen_GB
dc.contributor.authorSheridan-Leos, Normaen_US
dc.contributor.authorHartnaft, Stevenen_US
dc.author.detailsNorma Sheridan-Leos, RN MSN AOCN CPHQ, Sr. Clinical Quality Improvement Analyst, M. D. Anderson Cancer Center, Houston, Texas, USA, email: nsherida@mdanderson.org; Steven Hartnaft, MPH, CPHQ, City of Hope, Duarte, Californiaen_US
dc.identifier.urihttp://hdl.handle.net/10755/165125-
dc.description.abstractChemotherapy is associated with serious and potentially life threatening side effects, and thus has a high risk of causing significant patient harm when errors occur. Throughout the chemotherapy process, from prescribing to patient monitoring, there is a high risk for life threatening errors to occur. The Joint Commission on Accreditation of Healthcare Organizations expects healthcare organizations to conduct an annual proactive risk management activity for high risk processes. Failure Mode Effect Analysis (FMEA) is a proactive risk management assessment that has been successfully used in the non-healthcare industry to prevent errors from occurring. Because oncology nurses have many roles in the chemotherapy process, they are in a unique position to improve this process. The purpose of this project is to describe how an oncology nurse facilitated the FMEA process to proactively improve the safety of the chemotherapy process. The Oncology nurse facilitator used a variation of the FMEA process developed by the manufacturing industry. Using this process, all of the steps involved in chemotherapy were studied, failure modes were identified, risk analysis and prioritization of risk were completed. Then risk reduction techniques were used to proactively improve the chemotherapy process. FMEA is useful in identifying potential errors that oncology nurses and other healthcare team members may not realize exist at the organization. Although conducting a FMEA can not ensure that the chemotherapy process will be ôfail-safe,ö FMEA participants strongly felt that the FMEA process has: 1. Reduced the likelihood of errors occurring, 2. Helped them feel more confident in the chemotherapy process, 3. Improved understanding of the chemotherapy process, 4. Improved the working relationship with other members of the chemotherapy team. Promoting a culture of safety involves shifting from error measurement to a proactive assessment of potential harm. Because of their pivotal role in chemotherapy, oncology nurses are ideally suited to improve chemotherapy safety.en_GB
dc.date.available2011-10-27T12:12:58Z-
dc.date.issued2011-10-27en_GB
dc.date.accessioned2011-10-27T12:12:58Z-
dc.conference.date2007en_US
dc.conference.name32nd Annual Oncology Nursing Society Congressen_US
dc.conference.hostOncology Nursing Societyen_US
dc.conference.locationLas Vegas, Nevada, USAen_US
dc.description.noteThis is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.-
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.